Association between components of metabolic syndrome and elevated intraocular pressure

Krishnamoorthy Rathnakumar; Geetha Rajagopalan; Kaliaperumal Ramachandran; Venkatachalam Ramesh

doi:10.18203/2320-6012.ijrms20172986

Authors

Krishnamoorthy Rathnakumar Department of Ophthalmology, Sri Lakshmi Narayana Institute of Medical Sciences Pondicherry, India
Geetha Rajagopalan Department of Biochemistry, Sri Lakshmi Narayana Institute of Medical Sciences Pondicherry, India
Kaliaperumal Ramachandran Department of Biochemistry, Mahatma Gandhi Medical College Hospital and Research Institute, Pondicherry, India
Venkatachalam Ramesh Department of Ophthalmology, Sri Lakshmi Narayana Institute of Medical Sciences Pondicherry, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20172986

Keywords:

Central corneal thicknesses, Glaucoma, Intraocular pressure, Metabolic syndrome

Abstract

Background: Glaucoma is a group of eye diseases which result in damage to the optic nerve and ultimately vision loss. Elevated intraocular pressure (IOP) remains as the one major known risk factor for both the development and progression of glaucoma. Metabolic syndrome (MS) have been found to relate to elevated IOP. The aim of the study is to examine the association between MS and IOP by comparing central corneal thicknesses (CCT).

Methods: The study was carried out with 169 subjects consists of 94 were clinically diagnosed MS patients and 75 are healthy controls. Serum fasting glucose, triglyceride and HDL cholesterol levels were measured, and waist circumference, body mass index and blood pressure of all patients were recorded. Ophthalmological examinations, including IOP and CCT measurements were done on everyone.

Results: Higher IOP was observed in subjects with MS than those without MS. There was significant difference in the CCT values between the groups with and without MS (p<0.05). Most of the MS components were associated with IOP and CCT (p<0.05).

Conclusions: The study concludes that components of MS have strong association with IOP and CCT. The prevalence of MS is increasing rapidly in developing countries and the main cause for MS is sedentary lifestyle. Since there is relationship between MS and IOP, lifestyle intervention might have therapeutic potential to reduce IOP. Further studies are warranted to bring about the possible underlying relationship between components of MS and IOP.

Metrics

Metrics Loading ...

References

Weinreb RN, Tee Khaw P. Primary open-angle glaucoma. Lancet. 2004;9422:1711-20.

Lascaratos G, Garway-Heath DF, Burton R, Bruce C, Xing W, Crabb DP, et al. United Kingdom glaucoma treatment study group. The United Kingdom glaucoma treatment study: a multicentre, randomized, double-masked, placebo-controlled clinical trial: baseline characteristics. 2013;120(12):2540-45.

Rao HL, Addepali UK, Jonnadula GB, Kumbar T, Senthil S, Garudadri CS. Relationship between intraocular pressure and rate of visual field progression in treated glaucoma. J Glaucoma. 2013;22(9):719-24.

Kim YH, Jung SW, Nam GE, Do Han K, Bok AR, Baek SJ. High intraocular pressure is associated with cardiometabolic risk factors in South Korean men: Korean National Health and Nutrition Examination Survey, 2008-2010. Eye. 2014;28(6):672-9.

Chang YC, Lin JW, Wang LC, Chen HM, Hwang JJ, Chuang LM. Association of intraocular pressure with the metabolic syndrome and novel cardiometabolic risk factors. Eye. 2010 ;24(6):1037-43.

Newman-Casey PA, Talwar N, Nan B, Musch DC, Stein JD. The relationship between components of metabolic syndrome and open-angle glaucoma. Ophthalmol. 2011;118(7):1318-26.

Sahinoglu-Keskek N, Keskek SO, Cevher S, Kirim S, Kayiklik, Ortoglu, G, et al. Metabolic Syndrome as a risk factor for elevated intraocular pressure. Pakistan J Med Sci. 2014;30(3):477-82.

Wygnanski-Jaffe T, Bieran I, Tekes-Manova D, Morad Y, Ashkenazi I, Mezer E. Metabolic syndrome: a risk factor for high intraocular pressure in the Israeli population. Int J Ophthalmol. 2015;8:403-6.

Yokomichi H, Kashiwagi K, Kitamura K, Yoda Y, Tsuji M, Mochisuki M, et al. Evaluation of the associations between changes in intraocular pressure and metabolic syndrome parameters: a retrospective cohort study in Japan. BMJ Open. 2016;6:e010360.

Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach. Surv Ophthalmol. 2000;44:367-408.

Park SS, Lee EH, Jargal G, Paek D, Cho SI. The distribution of intraocular pressure and its association with metabolic syndrome in a community. J Prev Med Public Health. 2010;43:125-30.

Su DH, Wong TY, Foster PJ, Tay WT, Saw SM, Aung T. Central corneal thickness and its associations with ocular and systemic factors: the Singapore Malay Eye Study. Am J Ophthalmol. 2009;147(4):709-16.

Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III): JAMA. 2001;285(19):2486-97.

Fukuoka S, Aihara M, Iwase A, Araie M. Intraocular pressure in an ophthalmologically normal Japanese population. Acta Ophthalmol. 2008;86(4):434-39.

Tomoyose E, Higa A, Sakai H, Sawaguchi S, Iwase A, Tomidokoro A et al. Intraocular pressure and related systemic and ocular biometric factors in a population-based study in Japan: the Kumejima study. Am J Ophthalmol. 2010;150(2):279-86.

Lee JK, Lee JS, Kim YK. The relationship between intraocular pressure and health parameters. J Korean Ophthalmol Soc AID. 2009;50(1):105-12.

Memarzadeh F, Ying-Lai M, Azen SP, Varma R. Associations with intraocular pressure in Latinos: the Los Angeles Latino eye study. Am J Ophthalmol. 2008;146(1):69-76.

Mori K, Ando F, Nomura H, Sato Y, Shimokata H. Relationship between intraocular pressure and obesity in Japan. Int J Epidemiol. 2000;29:661-6.

Lin CP, Lin YS, Wu SC, Ko YS. Age and gender specific association between intraocular pressure and metabolic variables in a Taiwanese population. Eur J Intern Med. 2012;23:76-82.

Bulpitt CJ, Hodes C, Everott MR. Intraocular pressure and systemic blood pressure in the elderly. Br J Ophthalmol. 1975;59:717-20.

Hennis A, Wu SY, Nemesure B, Leske MC. Hypertension, diabetes and longitudinal changes in intraocular pressure. Ophthalmol. 2003;110:908-14.

Carel RS, Korczyn AD, Rock M, Goya I. Association between ocular pressure and certain parameters. Ophthalmol. 1984;91:311-14.

Mitchell P, Smith W, Chey T, Healey PR. Open-angle glaucoma and diabetes. The blue mountains eye study, Australia. Ophthalmol. 1997;104:712-8.

Mapstone R, Clark CV. Prevalence of diabetes in glaucoma. Br Med J. 1985;62:161-3.

Imai K, Hamaguchi M, Mori K, Takeda N, Fukui M, Kato T, et al. Metabolic syndrome as a risk factor for high-ocular tension. Int J Obes. 2010;34:1209-17.

Kitamura K, Yokomichi H, Yamagata Z, Tsuji M, Yoda Y, Kashiwagi K et al. Changes in intraocular pressure and associated systemic factors over 10 years in subjects without ocular diseases at baseline. J Glaucoma. 2014;23:185-9.

Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S, et al. The sympathetic nervous system and the metabolic syndrome. J Hypertens. 2007;25:909-20.

Yasuda K, Matsunaga T, Adachi T, Aoki N, Tsujimoto G, Tsuda K. Adrenergic receptor polymorphisms and autonomic nervous system function in human obesity. Trends Endocrinol Metab. 2006;17:269-75.

Belmonte C, Bartels SP, Liu JH, Neufeld AH. Effects of stimulation of the ocular sympathetic nerves on IOP and aqueous humour flow. Invest Ophthalmol Vis Sci. 1987;28:1649-54.

Inagaki Y, Mashima Y, Fuse N, Funayama T, Ohtake Y, Yasuda N, et al. Polymorphism of beta-adrenergic receptors and susceptibility to open-angle glaucoma. Mol Vis. 2006;12:673-80.

Blumenthal M, Blumenthal R, Peritz E, Best M. Seasonal variation in intraocular pressure. Am J Ophthalmol. 1970;69:608-10.

Matias I, Di Marzo V. Endocannabinoids and the control of energy balance. Trends Endocrinol Metab. 2007;18:27-37.

Jarvinen T, Pate DW, Laine K. Cannabinoids in the treatment of glaucoma. Pharmacol Ther. 2002;95:203-20.

Verkman AS. Role of aquaporin water channels in eye function. Exp Eye Res. 2003;76:137-43.

Su DH, Wong TY, Wong WL, Saw SM, Tan DT, Shen SY, et al. Diabetes, hyperglycemia, and central corneal thickness: the Singapore malay eye study. Ophthalmol. 2008;115:964-8.

Fischbarg J, Maurice DM. An update on corneal hydration control. Exp Eye Res. 2007;32:11-9.

Goldich Y, Barkana Y, Gerber Y, Rasko A, Morad Y, Harstein M, et al. Effect of diabetes mellitus on biomechanical parameters of the cornea. J Cataract Refract Surg. 2009;35:715-9.

Kotecha A, Oddone F, Sinapis C, Elsheikh A, Sinapis D, Sinapis A, et al. Corneal biomechanical characteristics in patients with diabetes mellitus. J Cataract Refract Surg. 2010;36:1822-8.